Diagnosis of early-onset LAMA2 MD is based on clinical examination, high serum creatine kinase (CK) concentrations, merosin deficiency detected by immunohistochemical staining of muscle or skin biopsy, and white matter changes on brain MRI. This evidence concerns the gene LAMA2 and Menkes disease.